ES2099021B1 - Composicion farmaceutica que tiene actividad analgesica. - Google Patents

Composicion farmaceutica que tiene actividad analgesica.

Info

Publication number
ES2099021B1
ES2099021B1 ES09401335A ES9401335A ES2099021B1 ES 2099021 B1 ES2099021 B1 ES 2099021B1 ES 09401335 A ES09401335 A ES 09401335A ES 9401335 A ES9401335 A ES 9401335A ES 2099021 B1 ES2099021 B1 ES 2099021B1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
analgesic activity
pharmaceutical
composition
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09401335A
Other languages
English (en)
Other versions
ES2099021A1 (es
Inventor
Federico Stroppolo
Daniele Bonadeo
Gian Franco Fornasini
Annibale Gazzaniga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Zambon SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Publication of ES2099021A1 publication Critical patent/ES2099021A1/es
Application granted granted Critical
Publication of ES2099021B1 publication Critical patent/ES2099021B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Abstract

COMPOSICION FARMACEUTICA QUE TIENE ACTIVIDAD ANALGESICA. ESTA COMPOSICION ESTA CONSTITUIDA ESENCIALMENTE POR UNA MEZCLA DE ARGININA Y (S)-IBUPROFEN, EN UNA RELACION MOLAR ENTRE 1,1 Y 1,9. ESTAS COMPOSICIONES FARMACEUTICAS SE PUEDEN FORMULAR PARA SU DOSIFICACION EN FORMA DE COMPRIMIDOS, GRANULADOS, POLVOS, JARABES O SOLUCIONES, MEZCLANDOLAS CON EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS COMPOSICIONES FARMACEUTICAS SE USAN PARA LA FORMULACION DE PREPARACIONES FARMACEUTICAS QUE TIENEN UNA SIGNIFICATIVA ANTICIPACION DEL EFECTO ANALGESICO.
ES09401335A 1993-06-21 1994-06-20 Composicion farmaceutica que tiene actividad analgesica. Expired - Fee Related ES2099021B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001325A IT1264856B1 (it) 1993-06-21 1993-06-21 Composizione farmaceutica ad attivita' analgesica

Publications (2)

Publication Number Publication Date
ES2099021A1 ES2099021A1 (es) 1997-05-01
ES2099021B1 true ES2099021B1 (es) 1998-01-16

Family

ID=11366436

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09401335A Expired - Fee Related ES2099021B1 (es) 1993-06-21 1994-06-20 Composicion farmaceutica que tiene actividad analgesica.

Country Status (15)

Country Link
US (2) US5500226A (es)
JP (1) JPH07101855A (es)
BE (1) BE1007194A3 (es)
CA (1) CA2125643C (es)
CH (1) CH687850A5 (es)
DE (1) DE4420856A1 (es)
DK (1) DK174687B1 (es)
ES (1) ES2099021B1 (es)
FR (1) FR2706892B1 (es)
GB (1) GB2279250B (es)
HU (1) HU211669A9 (es)
IT (1) IT1264856B1 (es)
NL (1) NL193820C (es)
NO (1) NO310443B1 (es)
SE (1) SE9402157L (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5707967A (en) * 1995-10-27 1998-01-13 Vanmoor; Arthur Pain relief compositions
US6177467B1 (en) 1996-09-26 2001-01-23 Oklahoma Medical Research Foundation Use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester and its derivatives in disease regression
WO1999051252A1 (en) * 1998-04-03 1999-10-14 The Daily Wellness Company Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1379226A2 (en) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Animal model for evaluating analgesics
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100678837B1 (ko) * 2005-01-03 2007-02-05 한미약품 주식회사 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
PT95564B (pt) * 1989-10-17 1997-11-28 Merck & Co Inc Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica

Also Published As

Publication number Publication date
CA2125643C (en) 2007-09-04
NO942343D0 (es) 1994-06-20
JPH07101855A (ja) 1995-04-18
US5645857A (en) 1997-07-08
DK174687B1 (da) 2003-09-15
FR2706892A1 (es) 1994-12-30
ES2099021A1 (es) 1997-05-01
NO310443B1 (no) 2001-07-09
GB2279250B (en) 1998-02-25
DK72594A (da) 1994-12-22
ITMI931325A0 (it) 1993-06-21
NL9401005A (nl) 1995-01-16
GB9410898D0 (en) 1994-07-20
CA2125643A1 (en) 1994-12-22
BE1007194A3 (fr) 1995-04-18
NL193820B (nl) 2000-08-01
NL193820C (nl) 2000-12-04
DE4420856A1 (de) 1994-12-22
GB2279250A (en) 1995-01-04
FR2706892B1 (es) 1995-10-20
HU211669A9 (en) 1995-12-28
NO942343L (no) 1994-12-22
SE9402157L (sv) 1994-12-22
US5500226A (en) 1996-03-19
CH687850A5 (it) 1997-03-14
IT1264856B1 (it) 1996-10-17
ITMI931325A1 (it) 1994-12-21
SE9402157D0 (sv) 1994-06-20

Similar Documents

Publication Publication Date Title
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
EP0543521A3 (en) High dosage topical forms of collagenase
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
MY118371A (en) Tetrahydrolipstatin containing compositions
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
AP1637A (en) Celecoxib compositions.
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
IT1247529B (it) Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
BR9508287A (pt) Formulaçao para a aplicaçao por inalaçao
RU92004549A (ru) Высокодозированные формы коллагеназы для наружного применения
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ATE295160T1 (de) Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
BR0211198A (pt) Composições farmacêuticas e seu uso
ES2109131B1 (es) Composicion farmaceutica que tiene actividad analgesica.
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
DE60035133D1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970501

Kind code of ref document: A1

Effective date: 19970501

FD2A Announcement of lapse in spain

Effective date: 20141120